Konjac Ceramide Induces Semaphorin 3A Expression via the MAPK/AP-1 Signaling Axis and RORα in Normal Human Epidermal Keratinocytes
Biomolecules · 21.05.2026 · 16 (5) · 755
DOI: 10.3390/biom16050755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.05.2026. Verfasst von Mirei Fujita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-…. Hauptthemen laut MEDLINE: Keratinocytes, Semaphorin-3A, Transcription Factor AP-1, MAP Kinase Signaling System. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, a Strategic Research Foundation Grant-aided Project for Private Universities.
Abstract (Originalsprache)
Epidermal hyperinnervation is a major cause of intractable itch in barrier dysfunction conditions such as atopic dermatitis. Keratinocyte-derived semaphorin 3A (Sema3A) suppresses epidermal hyperinnervation, but its expression is markedly reduced in barrier-disrupted skin. Although konjac ceramide (kCer) has been reported to act as a Sema3A-like ligand, the mechanisms by which it regulates Sema3A expression in keratinocytes remain unclear. Normal human epidermal keratinocytes (NHEKs) were treated with kCer, konjac glucosylceramide (kGlcCer), or C24 ceramide. Sema3A mRNA and protein levels were assessed by quantitative real-time PCR and enzyme-linked immunosorbent assay, respectively. The involvement of intracellular signaling was examined using mitogen-activated protein kinase (MAPK) inhibitors, activator protein-1 (AP-1) inhibitors, retinoic acid-related orphan receptor alpha (RORα) inverse agonists, and siRNAs targeting c-Jun, c-Fos, and RORα. kCer induced Sema3A expression in NHEKs more potently than kGlcCer or C24 ceramide and promoted Sema3A protein secretion. Pharmacological inhibition or genetic knockdown of MEK1/2, JNK, AP-1 components, or RORα significantly attenuated kCer-induced Sema3A expression, indicating involvement of the MAPK/AP-1 signaling axis and RORα. kCer upregulates Sema3A expression in human keratinocytes through MAPK/AP-1 signaling and RORα, suggesting it may represent a promising antipruritic agent for epidermal hyperinnervation associated with skin barrier dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan.
- Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu 279-0021, Chiba, Japan.
ORCID-Profile: Yayoi Kamata, Mitsutoshi Tominaga, Kenji Takamori
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- a Strategic Research Foundation Grant-aided Project for Private Universities
Zitieren
APA
Fujita, M., Kamata, Y., Tanemoto, N., Takahashi, N., Tominaga, M., & Takamori, K. (2026). Konjac Ceramide Induces Semaphorin 3A Expression via the MAPK/AP-1 Signaling Axis and RORα in Normal Human Epidermal Keratinocytes. Biomolecules, 16(5), 755. https://doi.org/10.3390/biom16050755
Vancouver
Fujita M, Kamata Y, Tanemoto N, Takahashi N, Tominaga M, Takamori K. Konjac Ceramide Induces Semaphorin 3A Expression via the MAPK/AP-1 Signaling Axis and RORα in Normal Human Epidermal Keratinocytes. Biomolecules. 2026;16(5):755. doi:10.3390/biom16050755
BibTeX
@article{Fujita2026,
author = {Fujita, Mirei and Kamata, Yayoi and Tanemoto, Nanami and Takahashi, Nobuaki and Tominaga, Mitsutoshi and Takamori, Kenji},
title = {Konjac Ceramide Induces Semaphorin 3A Expression via the MAPK/AP-1 Signaling Axis and RORα in Normal Human Epidermal Keratinocytes},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {755},
doi = {10.3390/biom16050755}
}
EUVIMED